Researcher profile

Jennifer A. Flegg

Jennifer A. Flegg contributes to research discovery and scholarly infrastructure.

ResearcherAffiliation not importedOpen to collaborate

Trust snapshot

Quick read

Trust 15 - UnverifiedVerification L1Unclaimed author
3works
0followers
2topics
4close collaborators

Actions

Decide how to stay connected

Follow researcher0

Identity and collaboration

How to connect with this researcher

Claiming links this public author record to a researcher profile and unlocks direct collaboration workflows.

Log in to claim

Direct collaboration

Open a focused conversation when the fit is right

Claim this author entity first to unlock direct invitations.

Research graph

See the researcher in context

Open full explorer

Inspect adjacent work, topics, institutions and collaborators without jumping out to a separate graph page.

Building this graph slice

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

3 published item(s)

preprint2026arXiv

Reduced-Precision Stochastic Simulation for Mathematical Biology

The stochastic simulation algorithm (SSA) is widely used to perform exact forward simulation of discrete stochastic processes in biology. However, the computational cost, driven by sequential event-by-event sampling across large ensembles, remains a computational barrier. We investigate whether reduced-precision floating-point arithmetic can accelerate SSA without degrading statistical fidelity, drawing on the success of reduced-precision methods in weather and climate modelling. We evaluate two strategies across five canonical models (birth--death, Schlögl, Telegraph, dimerisation, repressilator): (i) mixed precision, computing propensities in 16-bit while maintaining accumulators in 32-bit; and (ii) uniform precision, performing all arithmetic in 16-bit. Mixed-precision SSA produces ensemble statistics that closely match the 64-bit reference for all models, as measured by Kolmogorov--Smirnov tests and Wasserstein distances. Under uniform precision, deterministic rounding introduces systematic biases across several models, with catastrophic failures in some cases. Stochastic rounding (SR) and propensity normalisation eliminate these biases, restoring distributional fidelity across all models tested (KS $p > 0.05$). Our results establish mixed-precision SSA with SR as a viable acceleration strategy for mathematical biology: 16-bit formats shrink per-variable data size by $2$--$4\times$ relative to \texttt{fp32}/\texttt{fp64}, yielding comparable reductions in memory footprint and up to $\sim 1.5\times$ wall-clock speedup on CPU hardware that lacks native 16-bit arithmetic. As a hardware-level acceleration, mixed-precision SSA complements algorithmic methods such as tau-leaping and maps naturally onto modern GPU and TPU architectures with native 16-bit arithmetic.

preprint2022arXiv

A hybrid transmission model for Plasmodium vivax accounting for superinfection, immunity and the hypnozoite reservoir

Malaria is a vector-borne disease that exacts a grave toll in the Global South. The epidemiology of Plasmodium vivax, the most geographically expansive agent of human malaria, is characterised by the accrual of a reservoir of dormant parasites known as hypnozoites. Relapses, arising from hypnozoite activation events, comprise the majority of the blood-stage infection burden, with implications for the acquisition of immunity and the distribution of superinfection. Here, we construct a hybrid transmission model for P. vivax that concurrently accounts for the accrual of the hypnozoite reservoir, (blood-stage) superinfection and the acquisition of immunity. We begin by analytically characterising within-host dynamics as a function of mosquito-to-human transmission intensity, extending our previous model (comprising an open network of infinite server queues) to capture a discretised immunity level. To model transmission-blocking and antidisease immunity, we allow for geometric decay in the respective probabilities of successful human-to-mosquito transmission and symptomatic blood-stage infection as a function of this immunity level. Under a hybrid approximation -- whereby probabilistic within-host distributions are cast as expected population-level proportions -- we couple host and vector dynamics to recover a deterministic compartmental model in line with Ross-Macdonald theory. We then perform a steady-state analysis for this compartmental model, informed by the (analytic) distributions derived at the within-host level. To characterise transient dynamics, we derive a reduced system of integrodifferential equations (IDEs), likewise informed by our within-host queueing network, allowing us to recover population-level distributions for various quantities of epidemiological interest. Our model provides insights into important, but poorly understood, epidemiological features of P. vivax.

preprint2022arXiv

A model for malaria treatment evaluation in the presence of multiple species

Plasmodium (P.) falciparum and P. vivax are the two most common causes of malaria. While the majority of deaths and severe morbidity are due to P. falciparum, P. vivax poses a greater challenge to eliminating malaria outside of Africa due to its ability to form latent liver stage parasites (hypnozoites), which can cause relapsing episodes within an individual patient. In areas where P. falciparum and P. vivax are co-endemic, individuals can carry parasites of both species simultaneously. These mixed infections complicate dynamics in several ways; treatment of mixed infections will simultaneously affect both species, P. falciparum can mask the detection of P. vivax, and it has been hypothesised that clearing P. falciparum may trigger a relapse of dormant P. vivax. When mixed infections are treated for only blood-stage parasites, patients are at risk of relapse infections due to P. vivax hypnozoites. We present a stochastic mathematical model that captures interactions between P. falciparum and P. vivax, and incorporates both standard schizontocidal treatment (which targets blood-stage parasites) and radical treatment (which additionally targets liver-stage parasites). We apply this model to assess the implications of different treatment coverage of radical cure for mixed and P. vivax infections and a so-called "unified radical cure" treatment strategy for P. falciparum, P. vivax and mixed infections. We find that a unified radical cure strategy, with G6PD screening, leads to a substantially lower incidence of malaria cases and deaths overall. We perform a one-way sensitivity analysis to highlight important model parameters.